Pancreatic Cancer Research

ResearcherNingbo UniversityActive in the last 2 years

Bin Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4371-4746; OpenAlex author ID A5100392839. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper

Papers 6

  1. LncRNA MACC1-AS1 induces gemcitabine resistance in pancreatic cancer cells through suppressing ferroptosis. Co-author DOI 10.1038/s41420-024-01866-y↗
  2. Population pharmacokinetics of liposomal irinotecan in patients with cancer and exposure-safety analyses in patients with metastatic pancreatic cancer. Last author DOI 10.1002/psp4.12725↗
  3. First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study. Co-author DOI 10.1016/j.ejca.2021.03.028↗
  4. Selective activation of tumor-suppressive MAPKP signaling pathway by triptonide effectively inhibits pancreatic cancer cell tumorigenicity and tumor growth. Co-author DOI 10.1016/j.bcp.2019.05.010↗
  5. Combination of HDAC inhibitor TSA and silibinin induces cell cycle arrest and apoptosis by targeting survivin and cyclinB1/Cdk1 in pancreatic cancer cells. Co-author DOI 10.1016/j.biopha.2015.08.017↗
  6. Therapeutic potential of histone deacetylase inhibitors in pancreatic cancer. First author DOI 10.1016/j.canlet.2014.02.012↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zev A. Wainberg · 2 shared papers, 2021 · strength 0.24
  2. Andrew Peter Dean · 2 shared papers, 2021 · strength 0.24
  3. Farshid Dayyani · 2 shared papers, 2021 · strength 0.24
  4. Tanios Bekaii‐Saab · 2 shared papers, 2021 · strength 0.24
  5. Kabir Mody · 2 shared papers, 2021 · strength 0.24
  6. Teresa Mercade Macarulla · 2 shared papers, 2021 · strength 0.24
  7. Jiyun Zhu · 1 shared paper, 2024 · strength 0.21
  8. Siming Zheng · 1 shared paper, 2024 · strength 0.21
  9. Wan Feng · 2 shared papers, 2014–2015 · strength 0.13
  10. Xiaoping Zou · 2 shared papers, 2014–2015 · strength 0.13
  11. Karl Brendel · 1 shared paper, 2021 · strength 0.12
  12. Bruce Belanger · 1 shared paper, 2021 · strength 0.12
  13. Xingdong Xu · 1 shared paper, 2019 · strength 0.09
  14. Quansheng Zhou · 1 shared paper, 2019 · strength 0.09
  15. Ye Li · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.